We report an interesting clinical case of a patient carrying a specific BRCA2 germline variant affected by bone and hepa...
...BRCA2 genes not only have an increased lifetime risk of developing breast and ovarian cancer, but also a complicated rep...
...BRCA2 mutation and 1 patient with NET-O having a PIK3CA mutation. No other actionable mutations were identified.,No recu...
...BRCA2 mutations. Subgroup analyses revealed a larger proportion of BRCA1 mutations in TNBC than non-TNBC among patients ...
...BRCA2 c.156_157insAlu, and the remaining 80 were analyzed in parallel by Sanger sequencing for the BRCA1/BRCA2 genes and...
...BRCA2 mutations. One approach to expanding the use of PARP inhibitors to a wider range of tumors is to combine them with...
Women with a BRCA1 or BRCA2 mutation are at high risk for breast cancer and must make important decisions about breast c...
...BRCA2 (exons 3-11) and an intronic BRCA1 variant with unknown pathogenicity. The precision of high-resolution aCGH enabl...
...BRCA2 mutations. HGSC associated with BRCA2 but not BRCA1 mutations had significantly lower PNN compared to HGSC in non-...
...BRCA2. The BRCA1/2 HWA is based on the premise that pathogenic variants in these genes will be identified more often in ...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
